Finerenone-Empagliflozin Combination Therapy in Apparent Resistant Hypertension: A CONFIDENCE Trial Post Hoc Analysis.
- DOI
- 10.1016/j.jacadv.2026.103388
- Published
- 2026 Oct 23
- Container
- JACC. Advances
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jacadv.2026.103388,
title = {Finerenone-Empagliflozin Combination Therapy in Apparent Resistant Hypertension: A CONFIDENCE Trial Post Hoc Analysis.},
author = {Agarwal R and Navaneethan SD and Correa-Rotter R and Estrella MM and Heerspink HJL and McGill JB and Mottl AK and Nangaku M and Rosenstock J and Rossing P and Vaduganathan M and Morales J and Handelsman Y and Green JB and Mann JFE and Scott C and Li L and Brinker M and Weir MR},
year = {2026},
journal = {JACC. Advances},
doi = {10.1016/j.jacadv.2026.103388},
url = {https://doi.org/10.1016/j.jacadv.2026.103388}
}RIS
TY - JOUR TI - Finerenone-Empagliflozin Combination Therapy in Apparent Resistant Hypertension: A CONFIDENCE Trial Post Hoc Analysis. AU - Agarwal R AU - Navaneethan SD AU - Correa-Rotter R AU - Estrella MM AU - Heerspink HJL AU - McGill JB AU - Mottl AK AU - Nangaku M AU - Rosenstock J AU - Rossing P AU - Vaduganathan M AU - Morales J AU - Handelsman Y AU - Green JB AU - Mann JFE AU - Scott C AU - Li L AU - Brinker M AU - Weir MR PY - 2026 JO - JACC. Advances DO - 10.1016/j.jacadv.2026.103388 UR - https://doi.org/10.1016/j.jacadv.2026.103388 ER -
APA
R, A., SD, N., R, C., MM, E., HJL, H., JB, M., AK, M., M, N., J, R., P, R., M, V., J, M., Y, H., JB, G., JFE, M., C, S., L, L., M, B., & MR, W. (2026). Finerenone-Empagliflozin Combination Therapy in Apparent Resistant Hypertension: A CONFIDENCE Trial Post Hoc Analysis.. JACC. Advances. https://doi.org/10.1016/j.jacadv.2026.103388
Source records
- pubmed · retrieved 2026-11-10T13:20:33.478Z
- europe-pmc · retrieved 2026-11-10T13:20:33.485Z
- doaj · retrieved 2026-11-10T13:20:33.485Z